Rat GPC3(Glypican 3) ELISA Kit
Human Glypican 3 (GPC3) ELISA Kit |
RDR-GPC3-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 600 |
Human Glypican 3 (GPC3) ELISA Kit |
RDR-GPC3-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 830.4 |
Mouse Glypican 3 (GPC3) ELISA Kit |
RDR-GPC3-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 613.2 |
Mouse Glypican 3 (GPC3) ELISA Kit |
RDR-GPC3-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 850.8 |
Human Glypican 3 (GPC3) ELISA Kit |
RD-GPC3-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 573.6 |
Human Glypican 3 (GPC3) ELISA Kit |
RD-GPC3-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 794.4 |
Mouse Glypican 3 (GPC3) ELISA Kit |
RD-GPC3-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 586.8 |
Mouse Glypican 3 (GPC3) ELISA Kit |
RD-GPC3-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 812.4 |
Rat Glypican 3 (GPC3) ELISA Kit |
20-abx155595 |
Abbexa |
-
EUR 8684.40
-
EUR 4626.00
-
EUR 1074.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Rat Glypican 3 (GPC3) ELISA Kit |
abx255680-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Rat Glypican 3 (GPC3) ELISA Kit |
abx571478-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Rat Glypican-3(GPC3) ELISA kit |
CSB-EL009705RA-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Rat Glypican-3 (GPC3) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Rat Glypican-3(GPC3) ELISA kit |
1-CSB-EL009705RA |
Cusabio |
-
EUR 964.80
-
EUR 6118.80
-
EUR 3244.80
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Rat Glypican-3(GPC3) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Rat GPC3(Glypican 3) ELISA Kit |
ER1007 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.094 ng/ml |
Rat Glypican 3 (GPC3) ELISA Kit |
SEA971Ra-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5552.14 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Glypican 3 (GPC3) ELISA Kit |
SEA971Ra-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 562.42 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Glypican 3 (GPC3) ELISA Kit |
SEA971Ra-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 752.02 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Glypican 3 (GPC3) ELISA Kit |
SEA971Ra-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3024.07 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Glypican 3 (GPC3) ELISA Kit |
4-SEA971Ra |
Cloud-Clone |
-
EUR 5612.40
-
EUR 2965.20
-
EUR 752.40
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Glypican 3 (GPC3) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Rat Glypican 3 ELISA Kit (GPC3) |
RK03695 |
Abclonal |
96 Tests |
EUR 625.2 |
Rat Glypican-3 (Gpc3) |
1-CSB-YP009705RA |
Cusabio |
-
EUR 604.80
-
EUR 318.00
-
EUR 2198.40
-
EUR 915.60
-
EUR 1459.20
-
EUR 400.80
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Rat Glypican-3(Gpc3),partial expressed in Yeast |
ELISA kit for Rat GPC3 (Glypican 3) |
E-EL-R0974 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Rat GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Rat GPC3 (Glypican 3) |
ELK4296 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Glypican 3 from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Rat Glypican 3 (GPC3) CLIA Kit |
abx195537-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rat Glypican 3 (GPC3) CLIA Kit |
20-abx492280 |
Abbexa |
-
EUR 10282.80
-
EUR 5472.00
-
EUR 1262.40
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Rat Glypican 3 (GPC3) Protein |
20-abx653617 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2397.60
-
EUR 927.60
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Glypican 3 (GPC3) ELISA Kit |
20-abx151694 |
Abbexa |
-
EUR 7970.40
-
EUR 4250.40
-
EUR 990.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human Glypican 3 (GPC3) ELISA Kit |
abx051686-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Monkey Glypican 3 (GPC3) ELISA Kit |
abx359073-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Pig Glypican 3 (GPC3) ELISA Kit |
abx360627-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rabbit Glypican 3 (GPC3) ELISA Kit |
abx362738-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Sheep Glypican 3 (GPC3) ELISA Kit |
abx364415-96tests |
Abbexa |
96 tests |
EUR 1111.2 |
|
Mouse Glypican 3 (GPC3) ELISA Kit |
abx254136-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Human Glypican 3 (GPC3) ELISA Kit |
abx250341-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Chicken Glypican 3 (GPC3) ELISA Kit |
abx356317-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human GPC3(Glypican-3) ELISA Kit |
EH1096 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
Mouse GPC3(Glypican 3) ELISA Kit |
EM1084 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.094 ng/ml |
Human GPC3/ Glypican-3 ELISA Kit |
E1045Hu |
Sunlong |
1 Kit |
EUR 685.2 |
Human Glypican 3(GPC3)ELISA Kit |
GA-E1448HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human Glypican 3(GPC3)ELISA Kit |
GA-E1448HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Glypican 3 (GPC3) ELISA Kit |
SEA971Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5128.02 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Human Glypican 3 (GPC3) ELISA Kit |
SEA971Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 527.48 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Human Glypican 3 (GPC3) ELISA Kit |
SEA971Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 702.12 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Human Glypican 3 (GPC3) ELISA Kit |
SEA971Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2799.54 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Glypican 3 (GPC3) in serum, plasma, tissue homogenates and other biological fluids. |
Human Glypican 3 (GPC3) ELISA Kit |
4-SEA971Hu |
Cloud-Clone |
-
EUR 5188.80
-
EUR 2739.60
-
EUR 703.20
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Glypican 3 (GPC3) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Glypican 3 ELISA Kit (GPC3) |
RK01492 |
Abclonal |
96 Tests |
EUR 625.2 |
Glypican 3 (GPC3) Antibody |
20-abx100556 |
Abbexa |
-
EUR 477.60
-
EUR 159.60
-
EUR 1328.40
-
EUR 644.40
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Glypican 3 (GPC3) Antibody |
20-abx001589 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Glypican 3 (GPC3) Antibody |
20-abx125892 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Glypican 3 (GPC3) Antibody |
20-abx125893 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Glypican 3 (GPC3) Antibody |
20-abx112820 |
Abbexa |
|
|
|
Glypican 3 (GPC3) Antibody |
20-abx129737 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1362.00
-
EUR 661.20
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Glypican 3 (GPC3) Antibody |
abx015875-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
Glypican 3 (GPC3) Antibody |
abx028330-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Glypican 3 (GPC3) Antibody |
abx028330-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Glypican 3 (GPC3) Antibody |
20-abx225197 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 376.80
|
|
|
Glypican 3 (GPC3) Antibody |
20-abx327568 |
Abbexa |
|
|
|
Glypican 3 (GPC3) Antibody |
abx233512-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Glypican 3 (GPC3) Antibody |
abx233513-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Glypican 3 (GPC3) Antibody |
20-abx172655 |
Abbexa |
-
EUR 376.80
-
EUR 944.40
-
EUR 493.20
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Glypican 3 (GPC3) Antibody |
20-abx172656 |
Abbexa |
|
|
|
Glypican 3 (GPC3) Antibody |
20-abx176683 |
Abbexa |
|
|
|
glypican-3(GPC3)Antigen |
E62C02801 |
EnoGene |
20ug |
EUR 458.4 |
Recombinant Glypican 3 (GPC3) |
4-RPA971Hu01 |
Cloud-Clone |
-
EUR 528.58
-
EUR 265.20
-
EUR 1652.16
-
EUR 630.72
-
EUR 1141.44
-
EUR 429.60
-
EUR 3950.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Glypican 3 expressed in: E.coli |
Recombinant Glypican 3 (GPC3) |
4-RPA971Mu01 |
Cloud-Clone |
-
EUR 569.44
-
EUR 276.00
-
EUR 1805.38
-
EUR 681.79
-
EUR 1243.58
-
EUR 456.00
-
EUR 4333.44
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Glypican 3 expressed in: E.coli |
Glypican 3 Antibody / GPC3 |
V2536-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2536-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2536IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2536SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm's tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm�s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2537-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2537-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2537CF555-100T |
NSJ Bioreagents |
100 Tests |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilms tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2537IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2537SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2538-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2538-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2538IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V2538SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V3270-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V3270-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V3270SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V3714-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V3714-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V3714IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V3714SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V3715-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V3715-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V3715IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V3715SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7027-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7027-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7027IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7027SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7261-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7261-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7261IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V7261SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt] |
Glypican 3 Antibody / GPC3 |
V4020-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V4020-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
Glypican 3 Antibody / GPC3 |
V4020SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Glypican-3 (GPC3) is a glycosylphospatidyl inositol-anchored membrane protein, which may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression is also found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100% in follicular carcinoma and 70% in papillary carcinoma. Expression of GPC3 in follicular carcinoma is significantly higher than that of follicular adenoma. In contrast, GPC3 is not expressed in anaplastic carcinoma. |
CLIA kit for Rat GPC3 (Glypican 3) |
E-CL-R0646 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Rat GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human GPC3 (Glypican 3) |
ELK2141 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Glypican 3 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
ELISA kit for Human Glypican-3 (GPC3) |
KTE62925-48T |
Abbkine |
48T |
EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human Glypican-3 (GPC3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Glypican-3 (GPC3) |
KTE62925-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2702.4 |
Description: Quantitative sandwich ELISA for measuring Human Glypican-3 (GPC3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Glypican-3 (GPC3) |
KTE62925-96T |
Abbkine |
96T |
EUR 686.4 |
Description: Quantitative sandwich ELISA for measuring Human Glypican-3 (GPC3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human GPC3 (Glypican 3) |
E-EL-H1712 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Mouse GPC3 (Glypican 3) |
E-EL-M0328 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Mouse GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
Human Glypican 3 (GPC3) CLIA Kit |
abx195535-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Mouse Glypican 3 (GPC3) CLIA Kit |
abx195536-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human Glypican 3 (GPC3) CLIA Kit |
20-abx492279 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Anti-Glypican 3/GPC3 Antibody |
A01922-2 |
BosterBio |
100ug/vial |
EUR 352.8 |
Glypican 3 / GPC3 Recombinant Protein |
11-400 |
ProSci |
0.1 mg |
EUR 682.8 |
Description: Glypican-3 (GPC3) is also known as Intestinal protein OCI-5, GTR2-2, MXR7, which belongs to the glypican family. Glypican 3 / GPC-3 is highly expressed in lung, liver and kidney. Glypican-3 inhibits the dipeptidyl peptidase activity of DPP4. Glypican-3 may be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs, and also may play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. |
Mouse Glypican 3 (GPC3) Protein |
20-abx167236 |
Abbexa |
-
EUR 794.40
-
EUR 326.40
-
EUR 2431.20
-
EUR 944.40
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Glypican 3 (GPC3) Protein |
abx060155-100ug |
Abbexa |
100 ug |
EUR 1362 |
|
Human Glypican 3 (GPC3) Protein |
abx060263-1mg |
Abbexa |
1 mg |
EUR 2532 |
|
Human Glypican 3 (GPC3) Protein |
20-abx066892 |
Abbexa |
-
EUR 744.00
-
EUR 326.40
-
EUR 2230.80
-
EUR 878.40
-
EUR 543.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Glypican-3(GPC3/863) Antibody |
BNC040863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF405S conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC040863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF405S conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC050863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF405M conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC050863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF405M conjugate, Concentration: 0.1mg/mL |
Pan troglodytes Glypican-3 (GPC3) |
1-CSB-MP009705EQV |
Cusabio |
-
EUR 351.60
-
EUR 1155.60
-
EUR 490.80
-
EUR 860.40
|
|
|
Description: Recombinant Pan troglodytes Glypican-3 (GPC3) expressed in Mammalian cell |
Glypican-3(GPC3/863) Antibody |
BNCAP0863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCAP0863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCB0863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), Biotin conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCB0863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), Biotin conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCP0863-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Glypican-3(GPC3/863), PerCP conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCR0863-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Glypican-3(GPC3/863), RPE conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC940863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF594 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC940863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF594 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCA0863-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Glypican-3(GPC3/863), APC conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC810863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF680R conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC810863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF680R conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNUB0863-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against Glypican-3(GPC3/863), Concentration: 0.2mg/mL |
Glypican-3(GPC3/863) Antibody |
BNUB0863-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against Glypican-3(GPC3/863), Concentration: 0.2mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCH0863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNCH0863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC880863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF488A conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC880863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF488A conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC680863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF568 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC680863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF568 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC470863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF647 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC470863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF647 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC400863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF640R conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC400863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF640R conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC430863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF543 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC430863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF543 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC550863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF555 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC550863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF555 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC610863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF660R conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC610863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF660R conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC800863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF680 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC800863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF680 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC700863-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF770 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNC700863-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3(GPC3/863), CF770 conjugate, Concentration: 0.1mg/mL |
Glypican-3(GPC3/863) Antibody |
BNUM0863-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against Glypican-3(GPC3/863), 1mg/mL |
CLIA kit for Human GPC3 (Glypican 3) |
E-CL-H1076 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Human GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
CLIA kit for Mouse GPC3 (Glypican 3) |
E-CL-M0219 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Mouse GPC3 (Glypican 3) in samples from Serum, Plasma, Cell supernatant |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC041534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF405S conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC041534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF405S conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCAP1534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCAP1534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCH1534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCH1534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCP1534-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),PerCP conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCR1534-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),RPE conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC941534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF594 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC941534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF594 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCA1534-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),APC conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC811534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF680R conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC811534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF680R conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNUB1534-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R), Concentration: 0.2mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNUB1534-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R), Concentration: 0.2mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC881534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF488A conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC881534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF488A conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCB1534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Biotin conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNCB1534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),Biotin conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC611534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF660R conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC611534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF660R conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC681534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF568 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC681534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF568 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC431534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF543 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC431534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF543 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC471534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF647 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC471534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF647 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC401534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF640R conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC401534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF640R conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC551534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF555 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC551534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF555 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC801534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF680 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC801534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF680 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC051534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF405M conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC051534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF405M conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC701534-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF770 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNC701534-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R),CF770 conjugate, Concentration: 0.1mg/mL |
Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R) Antibody |
BNUM1534-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R), 1mg/mL |
Polyclonal Glypican 3 (GPC3) Antibody (Center) |
APR05748G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Glypican 3 (GPC3) (Center). This antibody is tested and proven to work in the following applications: |
Glypican-3(GPC3/863 + 1G12) Antibody |
BNC040864-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Glypican-3(GPC3/863 + 1G12), CF405S conjugate, Concentration: 0.1mg/mL |
Rat GPC3(Glypican 3) ELISA Kit